Gaps in care for rheumatoid arthritis: a population study.
暂无分享,去创建一个
Diane Lacaille | J. Esdaile | A. Anis | D. Guh | D. Lacaille | Aslam H Anis | John M Esdaile | Daphne P Guh
[1] V. Wright,et al. Osteoarthritis in weight-bearing wrists? , 1993, British journal of rheumatology.
[2] A Bouckaert,et al. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. , 1996, Journal of clinical epidemiology.
[3] P. Shekelle,et al. Quality of care for patients with rheumatoid arthritis. , 2000, JAMA.
[4] R. Grahame,et al. Quantitative microfocal radiography detects changes in erosion area in patients with early rheumatoid arthritis treated with myocrisine. , 1993, The Journal of rheumatology.
[5] A. van der Heide,et al. The Effectiveness of Early Treatment with Second-Line Antirheumatic Drugs , 1996, Annals of Internal Medicine.
[6] F. Wollheim. Approaches to rheumatoid arthritis in 2000 , 2001, Current opinion in rheumatology.
[7] A. Zwinderman,et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. , 2001, The American journal of medicine.
[8] J. Fries. Current treatment paradigms in rheumatoid arthritis. , 2000, Rheumatology.
[9] M. Dougados,et al. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide , 2002, Annals of the rheumatic diseases.
[10] C. Kwoh,et al. Guidelines for the management of rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. , 1996, Arthritis and rheumatism.
[11] U. Brodin,et al. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. , 1995, The Journal of rheumatology.
[12] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[13] G. Newsome. Guidelines for the management of rheumatoid arthritis: 2002 update. , 2002, Journal of the American Academy of Nurse Practitioners.
[14] M. Friger,et al. Clinical and radiographic outcomes of rheumatoid arthritis patients not treated with disease-modifying drugs. , 1998, Arthritis and rheumatism.
[15] R. Madhok,et al. Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study , 1998, Annals of the rheumatic diseases.
[16] J. Fries,et al. Progression of functional disability in patients with rheumatoid arthritis. Associations with rheumatology subspecialty care. , 1993, Archives of internal medicine.
[17] J. Kremer,et al. Combination Therapy with Multiple Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Preventive Strategy , 1999, Annals of Internal Medicine.
[18] S. Gabriel,et al. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists? , 2001, Arthritis and rheumatism.
[19] J. Fries,et al. Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. , 1996, Arthritis and rheumatism.
[20] P. Hannonen,et al. Disease-modifying anti-rheumatic drug use according to the 'sawtooth' treatment strategy improves the functional outcome in rheumatoid arthritis: results of a long-term follow-up study with review of the literature. , 2000, Rheumatology.
[21] C. Bombardier,et al. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. , 2000, The Journal of rheumatology.
[22] T. Pincus,et al. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. , 1984, Arthritis and rheumatism.
[23] R. Simms,et al. Guidelines for the Management of Rheumatoid Arthritis , 2002 .
[24] Outcomes for persons with rheumatoid arthritis with a rheumatologist versus a non-rheumatologist as the main physician for this condition. , 1998, Medical care.
[25] R. Yood,et al. Guidelines for the management of rheumatoid arthritis: 2002 Update. , 2002, Arthritis and rheumatism.
[26] J. Jollis,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. , 1993, Journal of clinical epidemiology.
[27] L. Criswell,et al. Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists. , 1997, The Journal of rheumatology.